Skip to main content
Premium Trial:

Request an Annual Quote

Namocell: Bob Cao

Single-cell biology company Namocell has appointed Bob Cao as VP of engineering. Cao spent 12 years at Becton Dickinson's BD Biosciences, where he led engineering efforts for multiple flow cytometry platforms. He also previously held product development lead roles at 10x Genomics and Complete Genomics.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.